LMG Life Sciences Awards EMEA 2025: open for entries

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

LMG Life Sciences Awards EMEA 2025: open for entries

Copy of EMEA awards 2024-Shortlist Announced-1200x627.png

It is time to submit nominations for the sixth annual Life Sciences Awards EMEA

The 2025 Life Sciences EMEA Awards is now open for entries. We are looking forward to reviewing and celebrating the industry's most impressive achievements and landmarks from the past year.

As ever, the Awards will recognise excellence in the life sciences legal market, showcasing the law firms, lawyers, in-house legal teams, and legal work that moved the dial in Europe, the Middle East & Africa's life sciences industry in 2024.

The deadline for entries is January 30 2025.

ENTRY FORMS

AWARDS GUIDELINES

ENTRY PORTAL

FAQs

Important Dates:

Entries Open

Entry Deadline

Shortlist Published

Gala Ceremony

December 18 2024

January 30 2025

March 2025

June 2025


All nominations must be entered through our Entry Portal. Nominations made in any other format or emailed to us will not be accepted.

For any questions about the awards or the research, please contact Life Sciences Awards editor Alex Griffiths or EMEA Research Director James Wilson.

LMG Life Sciences Awards

The LMG Life Sciences EMEA Awards recognise leading law firms and lawyers who specialise in the life sciences industry throughout the Europe, the Middle East and Africa.

The ceremony will celebrate outstanding legal work over the previous calendar year, showcasing firms and lawyers who are moving the dial for the life sciences industry. The award’s distinctive structure highlights firms and individuals that specialise in practice areas within life sciences.

LMG Life Sciences is a sister publication of Managing IP and works in collaboration with IFLR, Managing IP, and Benchmark Litigation to identify the best of the best from across the industry.

more from across site and SHARED ros bottom lb

More from across our site

François Pochart, Grégoire Desrousseaux and Lionel Martin, long-standing figures in the firm’s patent litigation team, are set to help launch a Paris-based litigation offering
The Unitary Patent has passed 100,000 registrations, but new data raises the question of whether 30% uptake is a ceiling or a staging post for further growth, say Michael Nielsen and Darren Smyth of EIP and Andrew Samm at Patently
The new generation of in-house IP leaders want commercial judgment, accessibility and flexibility, with AI raising expectations around both fees and delivery
The firm launched a San Diego office earlier this month, but California investment and expansion is far from complete
The industry’s response to AI requires an unfamiliar ingredient as firms battle to shape their futures
The firm is looking beyond replacing recently departed talent, betting instead on senior leaders to strengthen and expand its patent litigation platform
Olga Partington, director in Sterne Kessler’s biotechnology and chemical practice group, shares why a patent's vulnerability peaks when it is young, rather than when it is most valuable, under the PTAB's new framework
IP experts gathered in San Francisco last week to discuss the changing global SEP landscape and new licensing models for AI infrastructure
SKW Schwarz partner Daniel Kendziur explains how new green claims rules are changing his workload and bringing him into direct contact with marketing, PR and government affairs teams
The government is targeting earlier resolution of SEP disputes while ruling out a standalone IPEC rate determination track and restrictions on injunctions
Gift this article